HOME › DRUGS › EMICIZUMAB
ACTIVE SUBSTANCE / INN

EMICIZUMAB

Brand name(s): HEMLIBRA, Hemlibra
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA761083
Hemophilia A
ACTIVE SUBSTANCE
Emicizumab
REGULATORS
FDA · EMA
SPONSORS / MAH
Roche Registration Limited, GENENTECH INC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
HEMLIBRABLA761083GENENTECH INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
HemlibraRoche Registration LimitedAuthorised23/02/2018Hemophilia A

FULL INTELLIGENCE ON EMICIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →